Nanocarrier vaccine therapeutics for global infectious and chronic diseases

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines

(2022) Anna Lucia Tornesello et al.   Vaccines

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine

(2022) Karen J. Hager et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques

(2022) Ariane Volkmann et al.   Frontiers in Immunology

cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice

(2022) Wandi Zhu et al.   Molecular Therapy-Nucleic Acids

Nanocarrier Vaccines for SARS-CoV-2

(2021) Jatin Machhi et al.   ADVANCED DRUG DELIVERY REVIEWS

B cell memory: Understanding COVID-19

(2021) Isaak Quast et al.   IMMUNITY

The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2

(2021) Ryan D. Chow et al.   Nature Communications

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

(2021) Hana Štorkánová et al.   Scientific Reports

Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis

(2021) Hamed Nosrati et al.   JOURNAL OF NANOBIOTECHNOLOGY

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

(2021) Varnica Bajaj et al.   Frontiers in Physiology

Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants

(2021) Abdellatif Bouazzaoui et al.   Pharmaceutics

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

(2021) Alberto Cagigi et al.   Vaccines

Self-assembled peptide nanorod vaccine confers protection against influenza A virus

(2021) Ximena Zottig et al.   BIOMATERIALS

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

(2021) Denis Y Logunov et al.   LANCET

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2021) Zhiwei Wu et al.   LANCET INFECTIOUS DISEASES

mRNA vaccine for cancer immunotherapy

(2021) Lei Miao et al.   Molecular Cancer

Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach

(2021) Usman Ali Ashfaq et al.   PLoS One

A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

(2021) Laurence Chu et al.   VACCINE

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

(2021) Saghi Nooraei et al.   JOURNAL OF NANOBIOTECHNOLOGY

cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model

(2021) Elena V. Vassilieva et al.   Frontiers in Immunology

Changes in the Immune Phenotype and Gene Expression Profile Driven by a Novel Tuberculosis Nanovaccine: Short and Long-Term Post-immunization

(2021) Amparo Martínez-Pérez et al.   Frontiers in Immunology

Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3

(2021) Zoltán Kis et al.   Vaccines

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

(2021) Linde Schoenmaker et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses

(2021) Clayton J. Wollner et al.   JOURNAL OF VIROLOGY

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

(2021) Katherine R W Emary et al.   LANCET

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

(2021) Keith J Chappell et al.   LANCET INFECTIOUS DISEASES

China’s COVID vaccines are going global — but questions remain

(2021) Smriti Mallapaty   NATURE

Malaria vaccine shows promise — now come tougher trials

(2021) Heidi Ledford   NATURE

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

(2021) Prabhu S. Arunachalam et al.   NATURE

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19

(2021) Brian J. Ward et al.   NATURE MEDICINE

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

(2021) Jerald Sadoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

(2021) Vivek Shinde et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery

(2021) Kailash C. Petkar et al.   Pharmaceutics

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

(2021) Susanne Rauch et al.   npj Vaccines

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

(2021) Ali Pormohammad et al.   Vaccines

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

(2021) Yury Valdes-Balbin et al.   ACS Chemical Biology

Vaccine delivery systems toward lymph nodes

(2021) Yingyue Ding et al.   ADVANCED DRUG DELIVERY REVIEWS

Influenza vaccine: progress in a vaccine that elicits a broad immune response

(2021) Irina Isakova-Sivak et al.   Expert Review of Vaccines

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

(2021) Nawal Al Kaabi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

(2021) Angela Choi et al.   NATURE MEDICINE

Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy

(2021) Ying Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets

(2021) Rohan S.J. Ingrole et al.   VACCINE

Evidence for antibody as a protective correlate for COVID-19 vaccines

(2021) Kristen A. Earle et al.   VACCINE

Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?

(2021) Walter Doerfler   VIRUS RESEARCH

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals

(2021) Juan Li et al.   Human Vaccines & Immunotherapeutics

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases

(2021) Seyed Davoud Jazayeri et al.   Frontiers in Pharmacology

An Overview of Influenza Viruses and Vaccines

(2021) Rina Fajri Nuwarda et al.   Vaccines

Nano-Microparticle Platforms in Developing Next-Generation Vaccines

(2021) Giuseppe Cappellano et al.   Vaccines

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

(2021) Rebecca P. Payne et al.   CELL

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

(2021) Raches Ella et al.   LANCET

Cuba’s bet on home-grown COVID vaccines is paying off

(2021) Sara Reardon   NATURE

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis

(2021) Nadim Sharif et al.   Frontiers in Immunology

Current and future nanoparticle vaccines for COVID-19

(2021) Mai N. Vu et al.   EBioMedicine

VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants

(2021) Wasim A. Prates-Syed et al.   Vaccines

Nanoemulsions: Formulation, characterization, biological fate, and potential role against COVID-19 and other viral outbreaks

(2021) Hossam H. Tayeb et al.   Colloid and Interface Science Communications

Clinical Development of New TB Vaccines: Recent Advances and Next Steps

(2020) Mark Hatherill et al.   Frontiers in Microbiology

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

(2020) Alyse D. Portnoff et al.   Vaccines

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

(2020) Alec W. Freyn et al.   MOLECULAR THERAPY

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

(2020) Jingyou Yu et al.   SCIENCE

Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model

(2020) Donia Alson et al.   Frontiers in Immunology

A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain

(2020) Kurt A. Swanson et al.   Science Immunology

mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice

(2020) Xinyu Zhuang et al.   Vaccines

Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

(2020) Young Hun Chung et al.   ADVANCED DRUG DELIVERY REVIEWS

Polymeric vehicles for nucleic acid delivery

(2020) Alexandra S. Piotrowski-Daspit et al.   ADVANCED DRUG DELIVERY REVIEWS

Lipid nanoparticle technology for therapeutic gene regulation in the liver

(2020) Dominik Witzigmann et al.   ADVANCED DRUG DELIVERY REVIEWS

Controlling timing and location in vaccines

(2020) Darrell J. Irvine et al.   ADVANCED DRUG DELIVERY REVIEWS

SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen

(2020) Yunfei Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

(2020) Feng-Cai Zhu et al.   LANCET

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

(2020) Ugur Sahin et al.   NATURE

COVID-19 vaccine development and a potential nanomaterial path forward

(2020) Matthew D. Shin et al.   Nature Nanotechnology

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes

(2020) Timothy Donnison et al.   VACCINE

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

(2020) Paul F. McKay et al.   Nature Communications

A candidate multi-epitope vaccine against SARS-CoV-2

(2020) Tamalika Kar et al.   Scientific Reports

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

(2020) Federico Napolitano et al.   PLoS Neglected Tropical Diseases

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

(2020) Kevin P. Egan et al.   PLoS Pathogens

Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches

(2020) Rong Dong et al.   Frontiers in Immunology

Modified mRNA-LNP vaccines confer protection against experimental DENV-2 infection in mice

(2020) Mengling Zhang et al.   Molecular Therapy-Methods & Clinical Development

Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations

(2020) Jacob T. Martin et al.   npj Vaccines

Enhanced Oral Vaccine Efficacy of Polysaccharide-Coated Calcium Phosphate Nanoparticles

(2020) Pei Cao et al.   ACS Omega

Self-amplifying RNA vaccines for infectious diseases

(2020) Kristie Bloom et al.   GENE THERAPY

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

(2020) Gal Cafri et al.   JOURNAL OF CLINICAL INVESTIGATION

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

(2020) Denis Y Logunov et al.   LANCET

A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection

(2020) Valentina Bernasconi et al.   Mucosal Immunology

A DNA nanodevice-based vaccine for cancer immunotherapy

(2020) Shaoli Liu et al.   NATURE MATERIALS

Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health

(2020) Chelsea N. Fries et al.   Nature Nanotechnology

Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome

(2020) Stephen N. Crooke et al.   Scientific Reports

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

(2020) Lindsey R Baden et al.   Lancet HIV

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

(2020) Wen Shi Lee et al.   Nature Microbiology

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

(2020) Maheshi N Ramasamy et al.   LANCET

Eliciting B cell immunity against infectious diseases using nanovaccines

(2020) Ankur Singh   Nature Nanotechnology

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Infectious RNA vaccine protects mice against chikungunya virus infection

(2020) Inga Szurgot et al.   Scientific Reports

Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2

(2020) Esmaeil Behmard et al.   Scientific Reports

Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries

(2020) Claire E. Otero et al.   PLoS Pathogens

The known unknowns of T cell immunity to COVID-19

(2020) Annika C. Karlsson et al.   Science Immunology

Strategies to Improve Coverage of Typhoid Conjugate Vaccine (TCV) Immunization Campaign in Karachi, Pakistan

(2020) Farah Naz Qamar et al.   Vaccines

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2020) Yanjun Zhang et al.   LANCET INFECTIOUS DISEASES

DNA vaccines against COVID-19: Perspectives and challenges

(2020) Marcelle Moura Silveira et al.   LIFE SCIENCES

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

(2020) Andrew J Pollard et al.   LANCET INFECTIOUS DISEASES

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice

(2019) Marcelo M. Samsa et al.   MOLECULAR THERAPY

Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles

(2019) Aldenor G. Santos et al.   Scientific Reports

A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates

(2019) Miguel J. Rodo et al.   PLoS Pathogens

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

(2019) Kizzmekia S. Corbett et al.   mBio

Regulation of T cell expansion by antigen presentation dynamics

(2019) Andreas Mayer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

(2019) Masaru Kanekiyo et al.   NATURE IMMUNOLOGY

Factors That Influence the Immune Response to Vaccination

(2019) Petra Zimmermann et al.   CLINICAL MICROBIOLOGY REVIEWS

Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer

(2019) Lukai Zhai et al.   ANTIVIRAL RESEARCH

Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine

(2019) Nathan D. Donahue et al.   ADVANCED DRUG DELIVERY REVIEWS

Tetanus

(2019) Lam Minh Yen et al.   LANCET

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

(2019) Robert A. Feldman et al.   VACCINE

Multiscale engineering of immune cells and lymphoid organs

(2019) Sungwoong Kim et al.   Nature Reviews Materials

Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based Nanoparticle B-Cell Vaccines

(2019) Cornelia Barnowski et al.   Pharmaceutics

Neutral lipopolyplexes for in vivo delivery of conventional and replicative RNA vaccine

(2019) Federico Perche et al.   Molecular Therapy-Nucleic Acids

Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination

(2019) Anna-Karin E. Palm et al.   Frontiers in Immunology

An overview of nanogel-based vaccines

(2019) Luis Hernández-Adame et al.   Expert Review of Vaccines

Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles

(2019) Mariane Melo et al.   MOLECULAR THERAPY

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control

(2019) Elena Tondini et al.   OncoImmunology

Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity

(2019) Daniel Sanchez-Guzman et al.   BIOMATERIALS

Ebola Vaccine Trials: Progress in Vaccine Safety and Immunogenicity

(2019) Keesha M. Matz et al.   Expert Review of Vaccines

Peptide-Based Vaccines: Current Progress and Future Challenges

(2019) Ryan J. Malonis et al.   CHEMICAL REVIEWS

Multiepitope Subunit Vaccine to Evoke Immune Response against Acute Encephalitis

(2019) Neeraj Kumar et al.   Journal of Chemical Information and Modeling

The complex challenges of HIV vaccine development require renewed and expanded global commitment

(2019) Linda-Gail Bekker et al.   LANCET

Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial

(2018) Janine R. Danko et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity

(2018) Rob J.W. Arts et al.   Cell Host & Microbe

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines

(2018) Jiemin Wang et al.   DRUG DELIVERY

Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection

(2018) Peter Hart et al.   MOLECULAR THERAPY

Potency of a Scalable Nanoparticulate Subunit Vaccine

(2018) Dongdong Qiao et al.   NANO LETTERS

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

(2018) Young-Tae Lee et al.   PLoS One

Tuberculosis vaccines: Opportunities and challenges

(2018) Bingdong Zhu et al.   RESPIROLOGY

Explanations for the high potency of HPV prophylactic vaccines

(2018) John Schiller et al.   VACCINE

Immune responses after live attenuated influenza vaccination

(2018) Kristin G.-I. Mohn et al.   Human Vaccines & Immunotherapeutics

Immunology and efficacy of MF59-adjuvanted vaccines

(2018) Eun-Ju Ko et al.   Human Vaccines & Immunotherapeutics

A Review of DNA Vaccines Against Influenza

(2018) Leo Yi Yang Lee et al.   Frontiers in Immunology

Next-Generation Vaccines Based on Bacille Calmette–Guérin

(2018) Natalie E. Nieuwenhuizen et al.   Frontiers in Immunology

Engineering DNA vaccines against infectious diseases

(2018) Jihui Lee et al.   Acta Biomaterialia

Use of plant viruses and virus-like particles for the creation of novel vaccines

(2018) Ina Balke et al.   ADVANCED DRUG DELIVERY REVIEWS

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

(2018) Norbert Pardi et al.   Nature Communications

Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches

(2018) Aqsa Ikram et al.   Scientific Reports

DNA Vaccines—How Far From Clinical Use?

(2018) Dominika Hobernik et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

(2018) David A. G. Skibinski et al.   Scientific Reports

The effect of antigen dose on T cell-targeting vaccine outcome

(2018) Rolf Billeskov et al.   Human Vaccines & Immunotherapeutics

Nanoparticle Vaccines Against Infectious Diseases

(2018) Rashmirekha Pati et al.   Frontiers in Immunology

Calcium phosphate nanoparticles as a new generation vaccine adjuvant

(2017) Yahua Lin et al.   Expert Review of Vaccines

Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure

(2017) Thomas Démoulins et al.   JOURNAL OF CONTROLLED RELEASE

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease

(2017) Michelle Meyer et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy

(2017) Surinder M. Singh et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Metallic nanoparticles for cancer immunotherapy

(2017) Emily Reiser Evans et al.   Materials Today

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

(2017) Kapil Bahl et al.   MOLECULAR THERAPY

Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes

(2017) Gale Smith et al.   VACCINE

DNA vaccines against leptospirosis: A literature review

(2017) Marcelle Moura Silveira et al.   VACCINE

Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants

(2017) Labdhi Seth et al.   VACCINE

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection

(2017) Christopher L Cooper et al.   Emerging Microbes & Infections

Escherichia coli-derived virus-like particles in vaccine development

(2017) Xiaofen Huang et al.   npj Vaccines

Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries

(2016) Katayi Mwila et al.   Clinical and Vaccine Immunology

Defending against smallpox: a focus on vaccines

(2016) Emily A. Voigt et al.   Expert Review of Vaccines

Natural STING Agonist as an “Ideal” Adjuvant for Cutaneous Vaccination

(2016) Ji Wang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis

(2016) Inmaculada Posadas et al.   Nanomedicine

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

(2016) Christopher C. Stobart et al.   Nature Communications

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

(2016) Margit Schnee et al.   PLoS Neglected Tropical Diseases

Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA

(2015) Corey J. Bishop et al.   Acta Biomaterialia

Current advances in self-assembled nanogel delivery systems for immunotherapy

(2015) Yoshiro Tahara et al.   ADVANCED DRUG DELIVERY REVIEWS

Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells

(2015) João Conde et al.   ADVANCED FUNCTIONAL MATERIALS

Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)

(2015) Ulrich Lächelt et al.   CHEMICAL REVIEWS

Gold nanoparticles and vaccine development

(2015) Jorge Alberto Salazar-González et al.   Expert Review of Vaccines

Malaria vaccine based on self-assembling protein nanoparticles

(2015) Peter Burkhard et al.   Expert Review of Vaccines

Molecular mechanisms for enhanced DNA vaccine immunogenicity

(2015) Lei Li et al.   Expert Review of Vaccines

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

(2015) Michela Brazzoli et al.   JOURNAL OF VIROLOGY

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

(2015) Hadi M Yassine et al.   NATURE MEDICINE

Advances in the development of influenza virus vaccines

(2015) Florian Krammer et al.   NATURE REVIEWS DRUG DISCOVERY

Immune correlates of vaccine protection against HIV-1 acquisition

(2015) Lawrence Corey et al.   Science Translational Medicine

Cancer vaccines

(2015) L. H. Butterfield   BMJ-British Medical Journal

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination

(2015) Aline Baldo et al.   Human Vaccines & Immunotherapeutics

Cancer vaccines

(2015) L. H. Butterfield   BMJ-British Medical Journal

Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

(2014) W. M. Bogers et al.   JOURNAL OF INFECTIOUS DISEASES

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

(2014) Luis A Brito et al.   MOLECULAR THERAPY

Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment

(2014) Heleen Dewitte et al.   Nano Today

Why haven't we made an efficacious vaccine for malaria?

(2013) Michelle N Wykes   EMBO REPORTS

Persistent Antigen and Germinal Center B Cells Sustain T Follicular Helper Cell Responses and Phenotype

(2013) Dirk Baumjohann et al.   IMMUNITY

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

(2013) Peter Pushko et al.   INTERVIROLOGY

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

(2013) Michele D Tameris et al.   LANCET

Nanovaccines and their mode of action

(2013) Mehfuz Zaman et al.   METHODS

Gold nanoparticle–M2e conjugate coformulated with CpG induces protective immunity against influenza A virus

(2013) Wenqian Tao et al.   Nanomedicine

Oncolytic myxoma virus: The path to clinic

(2013) Winnie M. Chan et al.   VACCINE

Immunogenicity of a recombinant measles HIV-1 subtype C vaccine

(2013) Richard Stebbings et al.   VACCINE

Nanoparticle vaccines

(2013) Liang Zhao et al.   VACCINE

Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

(2013) Armin Hekele et al.   Emerging Microbes & Infections

Secondary mechanisms of diversification in the human antibody repertoire

(2013) Bryan S. Briney et al.   Frontiers in Immunology

The Effect of Nanoparticle Polyethylene Glycol Surface Density on Ligand-Directed Tumor Targeting Studied in Vivo by Dual Modality Imaging

(2012) Sjoerd Hak et al.   ACS Nano

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

(2012) Barton F. Haynes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

(2012) Susanne H. Sheehy et al.   PLoS One

T cell vaccinology: Exploring the known unknowns

(2012) Matt A. Burchill et al.   VACCINE

Tetanus toxoid vaccine: Elimination of neonatal tetanus in selected states of India

(2012) Ramesh Verma et al.   Human Vaccines & Immunotherapeutics

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

(2011) Morgane Bomsel et al.   IMMUNITY

T-cell-inducing vaccines - what’s the future

(2011) Sarah C. Gilbert   IMMUNOLOGY

Immunological mechanisms of vaccination

(2011) Bali Pulendran et al.   NATURE IMMUNOLOGY

Partially Randomized, Non-Blinded Trial of DNA and MVA Therapeutic Vaccines Based on Hepatitis B Virus Surface Protein for Chronic HBV Infection

(2011) James S. Cavenaugh et al.   PLoS One

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

(2011) Muhammad Bakari et al.   VACCINE

From Vaccines to Memory and Back

(2010) Federica Sallusto et al.   IMMUNITY

Flagellin as an Adjuvant: Cellular Mechanisms and Potential

(2010) S. B. Mizel et al.   JOURNAL OF IMMUNOLOGY

The Achilles heel of BCG

(2010) Ian M. Orme   TUBERCULOSIS

An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice

(2010) Kai Hu et al.   VACCINE

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

(2009) Bernhards R. Ogutu et al.   PLoS One

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

(2008) Rafick-Pierre Sekaly   JOURNAL OF EXPERIMENTAL MEDICINE

What really happens to dendritic cells during malaria?

(2008) Michelle N. Wykes et al.   NATURE REVIEWS MICROBIOLOGY

Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells

(2008) Bingke Bai et al.   PLoS One

Antigen kinetics determines immune reactivity

(2008) Pål Johansen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA